Regentis Biomaterials Ltd. (RGNT) Stock Price

RGNTStock
$1.49
Market Cap$10.47M
P/E—
PEG Ratio—
Div yield—
Beta—

RGNT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-60.89%
Price vs S&P 500 (4W)-31.86%
VGM Score23.13

Industry Peers — Orthopedic & Prosthetic Devices(31)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
RGNTRegentis Biomaterials Ltd.
——D————$1.49
ISRGIntuitive Surgical Inc.DBB13.7x18.2%66.7%31.3%$426.70
EWEdwards Lifesciences CorpDCB7.7x6.7%77.8%18.2%$86.60
STESTERIS plcCCB3.6x13.8%44.4%18.9%$222.66
ZBHZimmer Biomet Holdings, Inc.BCB2.1x3.2%69.9%14.2%$94.98
SNNSmith & Nephew plcBCC1.9x6.2%68.2%12.9%$29.06
ALGNAlign Technology IncBDC2.5x10.3%69.0%13.2%$147.31
MSAMine Safety IncorporatedCCB3.5x6.8%47.6%21.2%$179.05
ESTAEstablishment Labs Holdings Inc.FAC7.2x20.0%70.5%-7.6%$59.18
ENOVEnovis CorporationBDC0.5x-6.0%61.4%-45.1%$19.59
CDRECadre Holdings, Inc.BCC1.6x8.6%41.8%10.1%$26.38

About Regentis Biomaterials Ltd.

Regentis Biomaterials develops regenerative medicine solutions for orthopedic tissue repair. Its lead product, GelrinC, is a cell-free hydrogel implant designed to treat cartilage injuries in the knee, based on the company's proprietary Gelrin platform. The company targets the significant market opportunity in orthopedic regenerative medicine.